Table S5 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma

Table S5 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma

<p>List of recurrent mutations with potential utility as neoantigens</p>

Bewaard in:

Bibliografische gegevens
Hoofdauteur:	Lijun Yao (15292963) (author)
Andere auteurs:	Julia T. Wang (15292966) (author), Reyka G. Jayasinghe (15131798) (author), Julie O'Neal (15292969) (author), Chia-Feng Tsai (15292972) (author), Michael P. Rettig (15292975) (author), Yizhe Song (15292978) (author), Ruiyang Liu (15292981) (author), Yanyan Zhao (15292984) (author), Omar M. Ibrahim (15292987) (author), Mark A. Fiala (15032471) (author), Julie M. Fortier (15292990) (author), Siqi Chen (15292993) (author), Leah Gehrs (15292996) (author), Fernanda Martins Rodrigues (15292999) (author), Michael C. Wendl (15293002) (author), Daniel Kohnen (15293005) (author), Andrew Shinkle (15293008) (author), Song Cao (15293011) (author), Steven M. Foltz (15293014) (author), Daniel Cui Zhou (15293017) (author), Erik Storrs (15293020) (author), Matthew A. Wyczalkowski (15293023) (author), Smrithi Mani (15293026) (author), Scott R. Goldsmith (15293029) (author), Ying Zhu (15293032) (author), Mark Hamilton (15131831) (author), Tao Liu (15293035) (author), Feng Chen (15293038) (author), Ravi Vij (15293041) (author), Li Ding (15061726) (author), John F. DiPersio (15293044) (author)
Gepubliceerd in:	2025
Onderwerpen:	Cancer Immuno-oncology Methods and Technology Hematological Cancers Myelomas Immunotherapy Single Cell Technologies
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items

Table S1 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
door: Lijun Yao (15292963)
Gepubliceerd in: (2025)

Table S2 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
door: Lijun Yao (15292963)
Gepubliceerd in: (2025)

Table S3 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
door: Lijun Yao (15292963)
Gepubliceerd in: (2025)

Table S4 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
door: Lijun Yao (15292963)
Gepubliceerd in: (2025)

Table S6 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
door: Lijun Yao (15292963)
Gepubliceerd in: (2025)

Supplementary Spreadsheet S5 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
door: Eileen M. Boyle (15015425)
Gepubliceerd in: (2025)

Supplementary Spreadsheet S1 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
door: Eileen M. Boyle (15015425)
Gepubliceerd in: (2025)

Supplementary Spreadsheet S10 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
door: Eileen M. Boyle (15015425)
Gepubliceerd in: (2025)

Supplementary Spreadsheet S11 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
door: Eileen M. Boyle (15015425)
Gepubliceerd in: (2025)

Supplementary Spreadsheet S12 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
door: Eileen M. Boyle (15015425)
Gepubliceerd in: (2025)

Supplementary Spreadsheet S2 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
door: Eileen M. Boyle (15015425)
Gepubliceerd in: (2025)

Supplementary Spreadsheet S3 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
door: Eileen M. Boyle (15015425)
Gepubliceerd in: (2025)

Supplementary Spreadsheet S4 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
door: Eileen M. Boyle (15015425)
Gepubliceerd in: (2025)

Supplementary Spreadsheet S6 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
door: Eileen M. Boyle (15015425)
Gepubliceerd in: (2025)

Supplementary Spreadsheet S7 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
door: Eileen M. Boyle (15015425)
Gepubliceerd in: (2025)

Supplementary Spreadsheet S8 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
door: Eileen M. Boyle (15015425)
Gepubliceerd in: (2025)

Supplementary Spreadsheet S9 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
door: Eileen M. Boyle (15015425)
Gepubliceerd in: (2025)

Supplementary Data S1 from BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma
door: Keiji Kurata (15055090)
Gepubliceerd in: (2025)

Supplementary Data S2 from BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma
door: Keiji Kurata (15055090)
Gepubliceerd in: (2025)

Supplementary Data S3 from BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma
door: Keiji Kurata (15055090)
Gepubliceerd in: (2025)

Supplementary Table 5 from Super Enhancer-Mediated Upregulation of <i>HJURP</i> Promotes Growth and Survival of t(4;14)-Positive Multiple Myeloma
door: Yunlu Jia (2012017)
Gepubliceerd in: (2025)

Supplementary Table 1 from Super Enhancer-Mediated Upregulation of <i>HJURP</i> Promotes Growth and Survival of t(4;14)-Positive Multiple Myeloma
door: Yunlu Jia (2012017)
Gepubliceerd in: (2025)

Supplementary Table 2 from Super Enhancer-Mediated Upregulation of <i>HJURP</i> Promotes Growth and Survival of t(4;14)-Positive Multiple Myeloma
door: Yunlu Jia (2012017)
Gepubliceerd in: (2025)

Supplementary Table 3 from Super Enhancer-Mediated Upregulation of <i>HJURP</i> Promotes Growth and Survival of t(4;14)-Positive Multiple Myeloma
door: Yunlu Jia (2012017)
Gepubliceerd in: (2025)

Supplementary table 5 from Single-Cell Transcriptomics Reveals Immune Reconstitution in Patients with R/R T-ALL/LBL Treated with Donor-Derived CD7 CAR-T Therapy
door: Wei Chen (15053713)
Gepubliceerd in: (2025)

Supplementary table 6 from Single-Cell Transcriptomics Reveals Immune Reconstitution in Patients with R/R T-ALL/LBL Treated with Donor-Derived CD7 CAR-T Therapy
door: Wei Chen (15053713)
Gepubliceerd in: (2025)

Supplementary table 7 from Single-Cell Transcriptomics Reveals Immune Reconstitution in Patients with R/R T-ALL/LBL Treated with Donor-Derived CD7 CAR-T Therapy
door: Wei Chen (15053713)
Gepubliceerd in: (2025)

Discovery and Characterization of Novel BLIMP‑1 Heterobifunctional Ligand-Directed Degraders
door: Bryan J. Simmons (22676881)
Gepubliceerd in: (2025)

Supplementary Data from NKG7 Is a T-cell–Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy
door: Ti Wen (15130158)
Gepubliceerd in: (2025)

Correlation between duration of first-line treatment with daratumumab, lenalidomide, and dexamethasone and overall survival in patients with transplant-ineligible multiple myeloma in Japan
door: Kazuhito Suzuki (22688384)
Gepubliceerd in: (2025)

Supplementary Table S1 from Integrative Single-Cell and Bulk Transcriptomes Analyses Identify Intrinsic HNSCC Subtypes with Distinct Prognoses and Therapeutic Vulnerabilities
door: Yibin Dai (16374331)
Gepubliceerd in: (2025)

Supplementary Table S2 from Integrative Single-Cell and Bulk Transcriptomes Analyses Identify Intrinsic HNSCC Subtypes with Distinct Prognoses and Therapeutic Vulnerabilities
door: Yibin Dai (16374331)
Gepubliceerd in: (2025)

Table S5 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
door: Stéphane Fattori (15048281)
Gepubliceerd in: (2025)

Supplementary Tables S1-S11 from Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic <i>TP53</i>-Mutant Clonal Hematopoiesis
door: Rathana Kim (15135915)
Gepubliceerd in: (2025)

File_S1 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
door: Stéphane Fattori (15048281)
Gepubliceerd in: (2025)

Table S1 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
door: Stéphane Fattori (15048281)
Gepubliceerd in: (2025)

Table S2 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
door: Stéphane Fattori (15048281)
Gepubliceerd in: (2025)

Table S3 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
door: Stéphane Fattori (15048281)
Gepubliceerd in: (2025)

Table S4 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
door: Stéphane Fattori (15048281)
Gepubliceerd in: (2025)

Table S6 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
door: Stéphane Fattori (15048281)
Gepubliceerd in: (2025)

Cannot write session to /tmp/vufind_sessions/sess_74letsncsnlrf8olvlm1h6u3bg